Recruiting Scleroderma Studies in Palo Alto
About Scleroderma Clinical Trials in Palo Alto
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 1 scleroderma clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 400 participants. Research is being sponsored by Scleroderma Research Foundation, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Palo Alto — FAQ
Are there scleroderma clinical trials in Palo Alto?
Yes, there are 1 scleroderma clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated July 20, 2026 from ClinicalTrials.gov